Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Lee Hambright
BERN
Lee Hambright
Bernstein
Wall Street Analyst
★★☆☆☆
#1959
on 13Foresight · ranked by our own returns
31%
Success Rate
-8.9%
Average Return
4 of 13 calls profitable · -15.0% vs benchmark
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 31% of Lee Hambright's ratings turned a profit when each position was held for 1 year — averaging -8.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

54 Buy 16 Hold 0 Sell
Lee's Stock Coverage 12 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
MDT
Medtronic
 Jun 04, 2026 BUY Buy
+23.5% avg upside
38 analysts
$97.00
22.22% Upside
 -3.2%
DXCM
Dexcom
 May 15, 2026 BUY Strong Buy
+38.6% avg upside
32 analysts
$77.00
6.24% Upside
 +18.7%
MDLN
Medline
 May 07, 2026 BUY Strong Buy
+42.9% avg upside
26 analysts
$54.00
50.29% Upside
 -14.1%
PODD
Insulet
 May 07, 2026 BUY Strong Buy
+79.0% avg upside
32 analysts
$200.00
37.17% Upside
 -6.7%
SYK
Stryker
 May 01, 2026 BUY Strong Buy
+24.0% avg upside
36 analysts
$410.00
33.22% Upside
 +3.0%
JNJ
Johnson & Johnson
 Apr 14, 2026 HOLD Strong Buy
-3.5% avg upside
36 analysts
 — -4.3%
BSX
Boston Scientific
 Feb 05, 2026 BUY Strong Buy
+72.9% avg upside
38 analysts
$112.00
147.34% Upside
 -41.6%
ISRG
Intuitive Surgical
 Jan 23, 2026 BUY Strong Buy
+29.4% avg upside
36 analysts
$750.00
84.41% Upside
 -22.4%
ABT
Abbott Laboratories
 Jan 23, 2026 BUY Strong Buy
+31.2% avg upside
35 analysts
$125.00
41.45% Upside
 -17.1%
EW
Edwards Lifesciences
 Jan 16, 2026 HOLD Strong Buy
+11.7% avg upside
34 analysts
 — +2.8%
TNDM
Tandem Diabetes Care
 Jan 16, 2026 HOLD Buy
+116.0% avg upside
29 analysts
 — -16.2%
ZBH
Zimmer Biomet Holdings
 Jan 16, 2026 HOLD Buy
+27.6% avg upside
37 analysts
$99.00
12.46% Upside
 +1.9%
🔒 7 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Lee Hambright — Frequently Asked Questions
How accurate are Lee Hambright's stock ratings?
Based on the calls 13Foresight could measure, about 31% of Lee's ratings were profitable over a one-year hold, with an average return of -8.6% per rating, or -14.8% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Lee ranked on 13Foresight?
Lee Hambright is currently ranked #1959 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Lee cover?
Lee most recently has ratings on MDT, DXCM, MDLN, PODD, SYK, JNJ, BSX, ISRG, ABT, EW, TNDM, ZBH. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.